71 related articles for article (PubMed ID: 991807)
1. [Pharmacokinetic profile of perphenazine enanthate].
Viala A
Encephale; 1976; 2(3):273-82. PubMed ID: 991807
[TBL] [Abstract][Full Text] [Related]
2. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
[TBL] [Abstract][Full Text] [Related]
3. ["Succinylacetone effect' after oral homogentisate loading].
Laberge C; Lescault A; Grenier A; Gagné R
Union Med Can; 1981 Jul; 110(7):621-5. PubMed ID: 7292795
[No Abstract] [Full Text] [Related]
4. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
5. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies on tritiated perphenazine: passage from blood to milk in cows and ewes.
Shani J; Ziv G; Givant Y; Buchman O; Sulman FG
Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):44-56. PubMed ID: 4824891
[No Abstract] [Full Text] [Related]
7. [Perphenazine enanthate. Results of a 1-year open multicenter study].
Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
[TBL] [Abstract][Full Text] [Related]
9. Effect of perphenazine enanthate in Pyrenean chamois (Rupicapra pyrenaica).
Marco I; Cabezón O; Mentaberre G; Fernández-Sirera L; Casas-Díaz E; Fernandez-Aguilar X; López-Olvera JR; Serrano E; Navarro-Gonzalez N; Lavín S; Manteca X
J Zoo Wildl Med; 2013 Dec; 44(4):1083-5. PubMed ID: 24450074
[TBL] [Abstract][Full Text] [Related]
10. Effect of perphenazine enanthate on open-field test behaviour and stress-induced hyperthermia in domestic sheep.
Pedernera-Romano C; Ruiz de la Torre JL; Badiella L; Manteca X
Pharmacol Biochem Behav; 2010 Jan; 94(3):329-32. PubMed ID: 19799930
[TBL] [Abstract][Full Text] [Related]
11. [Perphenazine enanthate in the treatment of chronic schizophrenia].
Kampman R; Leppäluoto V
Duodecim; 1970; 86(20):1167-70. PubMed ID: 5477736
[No Abstract] [Full Text] [Related]
12. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men.
Lindholm H; Gullberg B; Ohman A; Sedvall G
Psychopharmacology (Berl); 1978 Apr; 57(1):1-4. PubMed ID: 96459
[TBL] [Abstract][Full Text] [Related]
13. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
[TBL] [Abstract][Full Text] [Related]
14. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
Sassa S; Fujita H; Kappas A
Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic trial of reactive and neurotic depressions with an amitriptyline-perphenazine combination (long term results in 100 cases)].
Chateau R
Therapeutique; 1973; 49(5):393-5. PubMed ID: 4592773
[No Abstract] [Full Text] [Related]
16. Effects of perphenazine on imipramine metabolism in man.
Gram LF
Psychopharmacol Commun; 1975; 1(2):165-75. PubMed ID: 1223997
[TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
18. Oral intake of perphenazine decanoate.
Larsen NE
Ther Drug Monit; 1998 Dec; 20(6):724. PubMed ID: 9853996
[No Abstract] [Full Text] [Related]
19. The use of long-acting neuroleptics, perphenazine enanthate and pipothiazine palmitate in two horses.
McCrindle CM; Ebedes H; Swan GE
J S Afr Vet Assoc; 1989 Dec; 60(4):208-9. PubMed ID: 2577292
[TBL] [Abstract][Full Text] [Related]
20. High-dose treatment of rats with perphenazine enanthate.
Fog R; Pakkenberg H; Juul P; Bock E; Jorgensen OS; Andersen J
Psychopharmacology (Berl); 1976 Nov; 50(3):305-7. PubMed ID: 826978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
